Balwant Purohit's Insider Trades & SAST Disclosures
Balwant Purohit's most recent trade in Remus Pharmaceuticals Ltd. was a Buy of 1,000 Equity Shares done at an average price of Rs. 4320.4 . Disclosure was reported to the exchange on Sept. 8, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Balwant Purohit in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remus Pharma | Balwant Purohit | Director | Buy | 08 Sep 2023 | 1,000 | 2,000 | - | 4320.4 | 4,320,400 | 08 Sep 2023 08 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.